The global Cerebral Angiography Market is estimated to be valued at US$ 14.96 Bn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Cerebral angiography is a type of medical imaging that uses X-rays and digital subtraction angiography to visualize blood vessels in the brain and neck. Cerebral angiography is used to diagnose diseases of the blood vessels in the brain.

Market key trends:
One of the key trends in the cerebral angiography market is the increasing demand for minimally invasive angiography procedures. Advancements in medical imaging technologies have enabled the development of minimally invasive angiography procedures like CT angiography and MRI angiography which do not require catheter insertion. These angiography methods provide high resolution 3D images of the brain vasculature and have significantly lower procedural risk compared to traditional invasive cerebral angiography. Their minimal invasiveness and improved safety is driving increasing adoption.

Market key trends:
The Cerebral Angiography Market Growth has been witnessing increasing adoption of flat panel detector computed tomography angiography (FD-CTA) systems. Flat panel detector computed tomography angiography provides higher resolution imagery, which is important for accurate diagnosis of neurological disorders. It has emerged as an efficient alternative to traditional digital subtraction angiography (DSA) systems. Technological advancements leading to development of FD-CTA systems with improved functionalities and image quality are expected to support growth of the cerebral angiography market during the forecast period.

SWOT Analysis
Strength: Cerebral angiography is considered the gold standard technique for evaluating the brain and neck vasculature. It provides high quality images essential for accurate diagnosis and treatment planning.
Weakness: Cerebral angiography procedures are invasive in nature and carry risks of bleeding, infection, stroke, and damage to blood vessels and tissue. They also require hospital stay which increases costs.
Opportunity: Growing incidences of neurological disorders such as brain aneurysm, stroke, and trauma worldwide present significant growth opportunities. Increasing adoption of flat panel detector CTA systems also provides opportunities.
Threats: Presence of alternative non-invasive imaging modalities like MRI and CT scanning poses threat to market growth. High cost of angiography procedures and economic slowdowns can also negatively impact the market.

Key Takeaways
The global cerebral angiography market size was valued at US$ 14.96 Bn in 2023 and is expected to reach US$ 27.16 Bn by 2030, expanding at a CAGR of 6.1% during the forecast period. Growth of the market is primarily driven by rising geriatric population and increasing incidences of neurovascular diseases.

Regional analysis: North America dominated the global market in 2023 and is expected to maintain its lead position during the forecast period. Higher healthcare spending and rapid adoption of advanced technologies provide a favorable environment for market growth in the region. Asia Pacific is expected to exhibit the fastest growthrate over 2023-2030 owing to rising awareness, increasing healthcare expenditures, and expanding medical tourism industry.

Key players: Some of the key players operating in the cerebral angiography market are Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shimadzu Corporation, Hitachi, Ltd., Carestream Health, Inc., Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, AngioDynamics, Inc., Penumbra, Inc., MicroPort Scientific Corporation, Cook Medical LLC. Technological advancements, mergers & acquisitions, and geographic expansions are some of the growth strategies adopted by these companies.\

 

Read More: https://cmiresearch.blogspot.com/2023/11/growing-adoption-of-angiography.html